QuintilesIMS to Announce Third-Quarter 2017 Results on October 26, 2017
October 12 2017 - 4:15PM
Business Wire
Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE:Q) will
announce its third-quarter 2017 financial results before the market
opens on Thursday, October 26, 2017. The QuintilesIMS management
team will also host a conference call and webcast at 9:00 a.m.
Eastern Time on that date. The earnings release and accompanying
financial information will be posted on the QuintilesIMS Investor
Relations website at http://ir.quintilesims.com.
Interested parties are invited to listen to the live event and
view the presentation slides via webcast on the QuintilesIMS
Investor Relations website at http://ir.quintilesims.com. The
discussion also will be available by dialing +1-800-410-4983 in the
U.S. and Canada, or +1-303-223-4375 for international callers.
A replay of the webcast will be available approximately two
hours after the conclusion of the live event on October 26. To
access the webcast recording, visit http://ir.quintilesims.com.
About QuintilesIMSQuintilesIMS (NYSE:Q) is a leading
integrated information and technology-enabled healthcare service
provider worldwide, dedicated to helping its clients improve their
clinical, scientific and commercial results. Formed through the
merger of Quintiles Transnational and IMS Health, QuintilesIMS’s
approximately 55,000 employees conduct operations in more than 100
countries. Companies seeking to improve real-world patient outcomes
through treatment innovations, care provision and access can
leverage QuintilesIMS’s broad range of healthcare information,
technology and service solutions to drive new insights and
approaches. QuintilesIMS provides solutions that span clinical to
commercial, bringing customers a unique opportunity to realize the
full potential of innovations and advanced healthcare outcomes.
As a global leader in protecting individual patient privacy,
QuintilesIMS uses healthcare data to deliver critical, real-world
disease and treatment insights. Through a wide variety of
privacy-enhancing technologies and safeguards, QuintilesIMS
protects individual privacy while managing information to drive
healthcare forward. These insights and execution capabilities help
biotech, medical device and pharmaceutical companies, medical
researchers, government agencies, payers and other healthcare
stakeholders in the development and approval of new therapies, and
to identify unmet treatment needs and understand the safety,
effectiveness and value of pharmaceutical products in improving
overall health outcomes. To learn more, visit
www.QuintilesIMS.com.
QUINTILESIMSFIN
Click here to subscribe to Mobile Alerts for QuintilesIMS.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171012006358/en/
QuintilesIMSInvestor Relations:Andrew Markwick,
+1-973-257-7144andrew.markwick@quintilesims.comorMedia
Relations:Tor Constantino,
+1-484-567-6732tor.constantino@quintilesims.com
IQVIA (NYSE:IQV)
Historical Stock Chart
From Mar 2024 to Apr 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Apr 2023 to Apr 2024